NEW YORK (GenomeWeb) – Merck today announced it would join the Structural Genomics Consortium (SGC) by making a C$7.5 million (US$6 million) contribution to the network.

The investment supports research projects to develop molecular probes to study epigenetic mechanisms of gene regulation. Use of the probes will expand the understanding of biology in multiple disease areas, particularly cancer and inflammatory diseases, the firm said in a statement.

Merck and SGC said that the supported projects "focus on precompetitive research to develop" the chemical probes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.